| Record ID | marc_columbia/Columbia-extract-20221130-009.mrc:48691612:3293 |
| Source | marc_columbia |
| Download Link | /show-records/marc_columbia/Columbia-extract-20221130-009.mrc:48691612:3293?format=raw |
LEADER: 03293fam a2200361 a 4500
001 4047234
005 20221027024217.0
008 931005t19941994wiua b 001 0 eng c
010 $a 93039744
020 $a0299140709 :$c$40.00
035 $a(OCoLC)29185180
035 $a(OCoLC)ocm29185180
035 $9AKL9360HS
035 $a(NNC)4047234
035 $a4047234
040 $aDNLM/DLC$cDLC$dDLC$dOrLoB
050 00 $aRC280.B8$bL57 1994
060 00 $aWP 870 L857 1994
082 00 $a616.99/449061$220
245 00 $aLong-term tamoxifen treatment for breast cancer /$cedited by V. Craig Jordan.
260 $aMadison, Wis. :$bUniversity of Wisconsin Press,$c[1994], ©1994.
300 $axix, 289 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tThe Development of Tamoxifen for Breast Cancer Therapy /$rV. Craig Jordan --$g2.$tClinical Pharmacology and Endocrinology of Long-Term Tamoxifen Therapy /$rSusan M. Langan Fahey, V. Craig Jordan, Nancy F. Fritz, Simon P. Robinson, David Waters and Douglass C. Tormey --$g3.$tMultisystem Biological and Symptomatic Toxicity of Tamoxifen in Postmenopausal Women /$rRichard R. Love --$g4.$tEndocrine Therapy for the Premenopausal Woman /$rR. W. Blamey --$g5.$tThe Nolvadex Adjuvant Trial Organisation (NATO) and the Cancer Research Campaign (CRC) Trials of Adjuvant Tamoxifen Therapy /$rJ. Houghton, D. Riley and M. Baum --$g6.$tThe Stockholm Adjuvant Tamoxifen Trial /$rLars E. Rutqvist --$g7.$tMaintenance Tamoxifen after Induction Postoperative Chemotherapy in Node-Positive Breast Cancer Patients /$rD. C. Tormey, R. Gray, H. C. Falkson, K. Gilchrist, M. D. Abeloff and G. Falkson /$rparticipating investigators --
505 80 $g8.$tProlonged Tamoxifen Treatment of Early Breast Cancer: The Experience of the Italian Cooperative Group for Chemohormonal Therapy of Early Breast Cancer /$rFrancesco Boccardo, Domenico Amoroso, Alessandra Rubagotti, Mario Capellini, Paolo Pacini, Luigi Castagnetta, Adele Traina, Antonio Farris, Stefano Iacobelli, Giorgio Mustacchi, Italo Nenci, Adriano Piffanelli, Piero Sismondi, Corrado De Sanctis, Mario Mesiti, Luigi Gallo, Eugenio Villa and Guiseppe Schieppati /$rother participants in the GROCTA studies --$g9.$tInteractions of Tamoxifen with Cytotoxic Chemotherapy for Breast Cancer /$rC. K. Osborne --$g10.$tTamoxifen-Resistant Growth /$rDouglas M. Wolf, Marco M. Gottardis and V. Craig Jordan --$g11.$tA New Approach to Breast Cancer Therapy - Total Estrogen Ablation with Pure Antiestrogens /$rA. E. Wakeling --$g12.$tSymptomatic Side Effects of Tamoxifen Therapy /$rMichael Fritsch and Douglas M. Wolf --$g13.$tThe Prevention of Breast Cancer with Tamoxifen /$rMonica Morrow and V. Craig Jordan.
650 0 $aTamoxifen.$0http://id.loc.gov/authorities/subjects/sh85132219
650 0 $aBreast$xCancer$xChemotherapy.$0http://id.loc.gov/authorities/subjects/sh2009117562
650 2 $aBreast Neoplasms$xdrug therapy.$0https://id.nlm.nih.gov/mesh/D001943Q000188
650 2 $aTamoxifen.$0https://id.nlm.nih.gov/mesh/D013629
700 1 $aJordan, V. Craig$q(Virgil Craig)$0http://id.loc.gov/authorities/names/n82057300
852 00 $boff,hsl$hRC280.B8$iL57 1994